Home » Topics » BioWorld Science

BioWorld Science
RSS

Positive phase II data for eprenetapopt plus azacitidine in TP53 mutant MDS and AML

July 22, 2021

Sorrento initiates dosing in U.K. phase II study of COVI-DROPS in outpatient setting

July 22, 2021

Positive data reported from phase Ib study of IMT-002 in T1D with HLA-DQ8 trait

July 22, 2021

Medshine Discovery patents new KHK inhibitors for NASH

July 22, 2021

FDA clears IND for Viracta's all-oral combination regimen in EBV-positive solid tumors

July 22, 2021

FDA approves IND for phase I/II study of Zofin in COVID-19 long haulers

July 22, 2021

Studies show NNRTI MK-8507 can be used with islatravir, levonorgestrel/ethinyl estradiol

July 22, 2021

New CRISPR-Cas vector designs reduce vector size and increase vector titer for HIV/AIDS treatment

July 22, 2021

All together now: Cure research plays big role at IAS 2021

July 21, 2021

DSMB recommends continuation of phase II trial of ANVS-401 in Alzheimer's disease

July 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...